ABSTRACT
INTRODUCTION
Expression and purification of recombinant DPP4. Genomic DNA from T. forsythia and
144
Prev. intermedia was prepared as previously reported (34 reported (31). All constructs were confirmed by DNA sequencing. Escherichia coli XL-1 Blue C-terminus were induced with 0.2 mM isopropyl-thiogalactopyranoside at 30˚C for 4 h, then 160 purified from the bacterial cell lysate using TALON affinity chromatography, as previously 161 described (14).
163
Peptidase activity. Peptidase activity was determined as previously described (15). organisms were pre-incubated in 80 µl of 50 mM Na-phosphate buffer, pH 7.5, containing 5 mM 178 EDTA, 0.5 mM TLCK, and 30 µM E-64 for 10 min at 0˚C. A reaction was started by addition of 179 20 µl of GLP-1(7-37) or GIP(52-93) (20 µM) at 37˚C, then MS analysis was performed as 180 previously reported (14) . GLP-1(7-37) hydrolysis was further examined in the presence of 2% 181 heat-inactivated fetal calf serum (56˚C for 20 min) with P. gingivalis (8 µl of cell suspension,
9
A 600 = 2.0), T. forsythia, Prev. intermedia, and S. mutans (8 µl of cell suspension, A 600 = 10.0).
183
The reaction was stopped at the appropriate time point by addition of trifluoroacetic acid (0.1%),
184
then hydrolyzed products were adsorbed to a Millipore ZipTip-C18, washed with 0.1% 185 trifluoroacetic acid, and eluted with 50% acetonitrile containing 5 mg/ml of 186 α-cyano-4-hydroxycinnamic acid. Hydrolysis of 20 µM GLP-1(7-37) or GIP(52-93) was also 187 carried out with aliquots of DPP4 (5 -100 ng). The molecular masses of the products were 188 determined by mass spectrometry using a Voyager DE-Pro (Applied Biosynstems, Foster City,
189
CA) and a Bulker Ultraflex III (Billerica, MS).
191
Glucose tolerance test. All animal experiments were approved by the animal ethics 192 committee of Nagasaki University (no. 0911170797). C57BL/6N female mice were purchased 193 from Charles River Lab (Fukuoka, Japan) and maintained in a specific pathogen-free facility
194
under a 12 h-light, 12 h-dark cycle, then subjected to experiments at the age of 10 to 13 weeks.
195
Purified recombinant DPP4 was dialyzed against PBS at 4˚C, then sterilized with a membrane 196 filter (pore size = 0.22 µm). DPP4 activity in each fraction was determined using Gly-Pro-MCA. DPP4. In fact, the dpp4-disrupted P. gingivalis strain NDP200 completely lost its activity, and S.
253
mutans, a pathogen of dental caries, which does not possess the dpp4 gene showed no 254 hydrolyzing activity either. On the contrary, the activity was increased in strain KDP136
255
(Δkgp-rgpA-rgpB) as reported previously (15).
256
Three recombinant DPP4 were expressed and purified to homogeneity (≥ 95%) judged by 257 SDS-PAGE (Fig. 2) respectively, were abrogated in the presence of 0.5 mM TLCK and 30 µM E-64 (data not shown).
307
Then, MS analysis was performed in the presence of TLCK and E-64. Under these conditions, P. 
333
We found that recombinant TfDPP4 (pI = 6.1) was soluble and adequately recovered from 334 dialysis against PBS at pH 7.4 at 4˚C, whereas large portions of PgDPP4 (pI = 7.4) and PiDPP4
335
(pI = 7.9) were precipitated during dialysis. Accordingly, subsequent animal experiments were 336 performed with TfDPP4 due to its yield. The blood glucose concentration at 15 min after 337 glucose administration was substantially higher in the group that received TfDPP4 (1 U/mouse) 338 as compared to the control group given PBS (P < 0.001) (Fig. 6) hydrophobic, anionic, and cationic amino acid residues at the P1 and P2 positions, and P.
383
gingivalis periplasm-localized exopeptidases (14-16).
384
The present results showed the in vivo activity of bacterial DPP4. 
577
Low frequency of toothbrushing practices is an independent risk factor for diabetes mellitus 
